27612561|t|Participation in and adherence to physical exercise after completion of primary cancer treatment
27612561|a|The purpose of this study was to identify demographic, clinical, psychosocial, physical and environmental factors that are associated with participation in and adherence to a combined resistance and endurance exercise program among cancer survivors, shortly after completion of primary cancer treatment. Data from the randomized controlled Resistance and Endurance exercise After ChemoTherapy (REACT) study were used for this study. The participants of the REACT study were randomly allocated to either a high intensity (HI) or low -to- moderate intensity (LMI) exercise program. Patients ' participation rate was defined as the cancer survivors ' decision to participate in the REACT study. Exercise adherence reflected participants ' attendance to the scheduled exercise sessions and their compliance to the prescribed exercises. High session attendance rates were defined as attending at least 80 % of the sessions. High compliance rates were defined as performing at least of 90 % of the prescribed exercise across all sessions. Correlates of exercise adherence were studied separately for HI and LMI exercise. Demographic, clinical, and physical factors were assessed using self-reported questionnaires. Relevant clinical information was extracted from medical records. Multivariable logistic regression analyses were applied to identify correlates that were significantly associated with participation, high session attendance, high compliance with resistance and high compliance with endurance exercises. Participants were more likely to have higher education, be non-smokers, have lower psychological distress, higher outcome expectations, and perceive more exercise barriers than non-participants. In HI exercise, higher self-efficacy was significantly associated with high session attendance and high compliance with endurance exercises, and lower psychological distress was significantly associated with high compliance with resistance exercise s. In LMI exercise, being a non-smoker was significantly associated with high compliance with resistance exercises and higher BMI was significantly associated with high compliance with resistance and endurance exercises. Furthermore, breast cancer survivors were less likely to report high compliance with resistance and endurance exercises in LMI exercise compared to survivors of other types of cancer. The discriminative ability of the multivariable models ranged from 0.62 to 0.75. Several demographic, clinical and psychosocial factors were associated with participation in and adherence to exercise among cancer survivors. Psychosocial factors were more strongly associated with adherence in HI than LMI exercise. This study was registered at the Netherlands Trial Register [NTR2153] on the 5(th) of January 2010.
27612561	0	13	Participation	T169	C0679823
27612561	21	30	adherence	T169	C1510802
27612561	34	51	physical exercise	T056	C0015259
27612561	58	68	completion	T080	C0205197
27612561	72	86	primary cancer	T191	C1306459
27612561	87	96	treatment	T061	C0087111
27612561	101	108	purpose	T169	C1285529
27612561	117	122	study	T062	C2603343
27612561	130	138	identify	T041	C0020792
27612561	139	150	demographic	T078	C0011292
27612561	152	160	clinical	T080	C0205210
27612561	162	174	psychosocial	T169	C0542298
27612561	176	184	physical	T169	C0205485
27612561	189	202	environmental	T082	C0014406
27612561	203	210	factors	T169	C1521761
27612561	220	235	associated with	T080	C0332281
27612561	236	249	participation	T169	C0679823
27612561	257	266	adherence	T169	C1510802
27612561	272	280	combined	T080	C0205195
27612561	281	291	resistance	T169	C4281815
27612561	296	314	endurance exercise	T061	C0419120
27612561	315	322	program	T169	C3484370
27612561	329	345	cancer survivors	T101	C1516231
27612561	361	371	completion	T080	C0205197
27612561	375	389	primary cancer	T191	C1306459
27612561	390	399	treatment	T061	C0087111
27612561	401	405	Data	T078	C1511726
27612561	415	425	randomized	T033	C3815594
27612561	426	436	controlled	T169	C2587213
27612561	437	489	Resistance and Endurance exercise After ChemoTherapy	T170	C0282574
27612561	491	496	REACT	T170	C0282574
27612561	498	503	study	T062	C2603343
27612561	523	528	study	T062	C2603343
27612561	534	546	participants	T098	C0679646
27612561	554	559	REACT	T170	C0282574
27612561	560	565	study	T062	C2603343
27612561	571	579	randomly	T080	C0439605
27612561	580	589	allocated	T052	C1706778
27612561	602	616	high intensity	T185	C4081854
27612561	618	620	HI	T185	C4081854
27612561	625	628	low	T080	C0205251
27612561	634	652	moderate intensity	T185	C4081855
27612561	654	657	LMI	T080	C0522510
27612561	659	667	exercise	T056	C0015259
27612561	668	675	program	T169	C3484370
27612561	677	685	Patients	T101	C0030705
27612561	688	701	participation	T169	C0679823
27612561	702	706	rate	T081	C1521828
27612561	726	742	cancer survivors	T101	C1516231
27612561	757	768	participate	T169	C0679823
27612561	776	781	REACT	T170	C0282574
27612561	782	787	study	T062	C2603343
27612561	789	797	Exercise	T056	C0015259
27612561	798	807	adherence	T169	C1510802
27612561	808	817	reflected	T041	C0558058
27612561	818	830	participants	T098	C0679646
27612561	833	843	attendance	T052	C2827364
27612561	851	860	scheduled	T080	C0205539
27612561	861	869	exercise	T056	C0015259
27612561	870	878	sessions	T051	C1883016
27612561	889	899	compliance	T055	C1321605
27612561	907	917	prescribed	T058	C0278329
27612561	918	927	exercises	T056	C0015259
27612561	929	933	High	T080	C0205250
27612561	934	941	session	T051	C1883016
27612561	942	952	attendance	T052	C2827364
27612561	953	958	rates	T081	C1521828
27612561	975	984	attending	T169	C1999232
27612561	1006	1014	sessions	T051	C1883016
27612561	1016	1020	High	T080	C0205250
27612561	1021	1031	compliance	T055	C1321605
27612561	1032	1037	rates	T081	C1521828
27612561	1054	1064	performing	T169	C0884358
27612561	1089	1099	prescribed	T058	C0278329
27612561	1100	1108	exercise	T056	C0015259
27612561	1120	1128	sessions	T051	C1883016
27612561	1130	1140	Correlates	T080	C1707520
27612561	1144	1152	exercise	T056	C0015259
27612561	1153	1162	adherence	T169	C1510802
27612561	1168	1175	studied	T062	C2603343
27612561	1176	1186	separately	T080	C0443299
27612561	1191	1193	HI	T185	C4081854
27612561	1198	1201	LMI	T080	C0522510
27612561	1202	1210	exercise	T056	C0015259
27612561	1212	1223	Demographic	T078	C0011292
27612561	1225	1233	clinical	T080	C0205210
27612561	1239	1247	physical	T169	C0205485
27612561	1248	1255	factors	T169	C1521761
27612561	1261	1269	assessed	T052	C1516048
27612561	1276	1289	self-reported	T062	C0681906
27612561	1290	1304	questionnaires	T170	C0034394
27612561	1306	1314	Relevant	T080	C2347946
27612561	1315	1335	clinical information	T170	C2708733
27612561	1340	1349	extracted	T169	C1301820
27612561	1355	1370	medical records	T170	C0025102
27612561	1372	1414	Multivariable logistic regression analyses	UnknownType	C0681925
27612561	1420	1427	applied	T169	C4048755
27612561	1431	1439	identify	T041	C0020792
27612561	1440	1450	correlates	T080	C1707520
27612561	1461	1474	significantly	T078	C0750502
27612561	1475	1490	associated with	T080	C0332281
27612561	1491	1504	participation	T169	C0679823
27612561	1506	1510	high	T080	C0205250
27612561	1511	1518	session	T051	C1883016
27612561	1519	1529	attendance	T052	C2827364
27612561	1531	1535	high	T080	C0205250
27612561	1536	1546	compliance	T055	C1321605
27612561	1552	1562	resistance	T169	C4281815
27612561	1567	1571	high	T080	C0205250
27612561	1572	1582	compliance	T055	C1321605
27612561	1588	1607	endurance exercises	T061	C0419120
27612561	1609	1621	Participants	T098	C0679646
27612561	1627	1638	more likely	T033	C3840799
27612561	1647	1663	higher education	T170	C0424933
27612561	1668	1679	non-smokers	T033	C0337672
27612561	1686	1691	lower	T080	C0205251
27612561	1692	1714	psychological distress	T048	C0815107
27612561	1716	1722	higher	T080	C0205250
27612561	1723	1730	outcome	T080	C0085415
27612561	1731	1743	expectations	T078	C0679138
27612561	1749	1757	perceive	T041	C0030971
27612561	1758	1762	more	T081	C0205172
27612561	1763	1771	exercise	T056	C0015259
27612561	1772	1780	barriers	T080	C0679881
27612561	1786	1802	non-participants	T098	C1257890
27612561	1807	1809	HI	T185	C4081854
27612561	1810	1818	exercise	T056	C0015259
27612561	1820	1826	higher	T080	C0205250
27612561	1827	1840	self-efficacy	T041	C0600564
27612561	1845	1858	significantly	T078	C0750502
27612561	1859	1874	associated with	T080	C0332281
27612561	1875	1879	high	T080	C0205250
27612561	1880	1887	session	T051	C1883016
27612561	1888	1898	attendance	T052	C2827364
27612561	1903	1907	high	T080	C0205250
27612561	1908	1918	compliance	T055	C1321605
27612561	1924	1943	endurance exercises	T061	C0419120
27612561	1949	1954	lower	T080	C0205251
27612561	1955	1977	psychological distress	T048	C0815107
27612561	1982	1995	significantly	T078	C0750502
27612561	1996	2011	associated with	T080	C0332281
27612561	2012	2016	high	T080	C0205250
27612561	2017	2027	compliance	T055	C1321605
27612561	2033	2043	resistance	T169	C4281815
27612561	2044	2052	exercise	T056	C0015259
27612561	2059	2062	LMI	T080	C0522510
27612561	2063	2071	exercise	T056	C0015259
27612561	2081	2091	non-smoker	T033	C0337672
27612561	2096	2109	significantly	T078	C0750502
27612561	2110	2125	associated with	T080	C0332281
27612561	2126	2130	high	T080	C0205250
27612561	2131	2141	compliance	T055	C1321605
27612561	2147	2157	resistance	T169	C4281815
27612561	2158	2167	exercises	T056	C0015259
27612561	2172	2178	higher	T080	C0205250
27612561	2179	2182	BMI	T201	C1305855
27612561	2187	2200	significantly	T078	C0750502
27612561	2201	2216	associated with	T080	C0332281
27612561	2217	2221	high	T080	C0205250
27612561	2222	2232	compliance	T055	C1321605
27612561	2238	2248	resistance	T169	C4281815
27612561	2253	2272	endurance exercises	T061	C0419120
27612561	2287	2310	breast cancer survivors	T101	C1516231
27612561	2316	2320	less	T081	C0439092
27612561	2321	2327	likely	T078	C0750492
27612561	2331	2337	report	T058	C0700287
27612561	2338	2342	high	T080	C0205250
27612561	2343	2353	compliance	T055	C1321605
27612561	2359	2369	resistance	T169	C4281815
27612561	2374	2393	endurance exercises	T061	C0419120
27612561	2397	2400	LMI	T080	C0522510
27612561	2401	2409	exercise	T056	C0015259
27612561	2410	2418	compared	T052	C1707455
27612561	2422	2431	survivors	T101	C0206194
27612561	2450	2456	cancer	T191	C0006826
27612561	2462	2476	discriminative	T041	C0012632
27612561	2477	2484	ability	T032	C0085732
27612561	2492	2505	multivariable	T080	C0439828
27612561	2506	2512	models	T170	C3161035
27612561	2513	2519	ranged	T081	C1514721
27612561	2547	2558	demographic	T078	C0011292
27612561	2560	2568	clinical	T080	C0205210
27612561	2573	2585	psychosocial	T169	C0542298
27612561	2586	2593	factors	T169	C1521761
27612561	2599	2614	associated with	T080	C0332281
27612561	2615	2628	participation	T169	C0679823
27612561	2636	2645	adherence	T169	C1510802
27612561	2649	2657	exercise	T056	C0015259
27612561	2664	2680	cancer survivors	T101	C1516231
27612561	2682	2694	Psychosocial	T169	C0542298
27612561	2695	2702	factors	T169	C1521761
27612561	2708	2712	more	T081	C0205172
27612561	2713	2721	strongly	T080	C0442821
27612561	2722	2737	associated with	T080	C0332281
27612561	2738	2747	adherence	T169	C1510802
27612561	2751	2753	HI	T185	C4081854
27612561	2759	2762	LMI	T080	C0522510
27612561	2763	2771	exercise	T056	C0015259
27612561	2778	2783	study	T062	C2603343
27612561	2788	2798	registered	T170	C0684224
27612561	2806	2832	Netherlands Trial Register	T170	C0034975
27612561	2834	2841	NTR2153	T170	C0034975